Multi-center MRD Registry for Inflammatory Breast Cancer

Description

To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.

Conditions

Breast Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.

Multi-center MRD Registry for Inflammatory Breast Cancer

Multi-center MRD Registry for Inflammatory Breast Cancer

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Houston

MD Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Female or males ≥18 years of age with the ability to understand and sign a written
  • * Participants who have a clinical diagnosis of stage III or IV inflammatory breast cancer (IBC).
  • * Participants who are planning to have or already completed a minimum of one blood draw for Signatera testing, for which the result and clinical data can be deposited into the study database.
  • * Participants must be within eight months of diagnosis and have not undergone breast surgery for this diagnosis of breast cancer.
  • * Participants must be English-speaking.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Sadia Saleem, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2032-05-31